Table 1.
General (n = 24) | Regional (n = 137) | P value | |
---|---|---|---|
Age (yr) | 67.5 ± 9.0 | 62.4 ± 10.8 | 0.029* |
Sex (M/F) | 17/7 | 107/30 | 0.438 |
Weight (kg) | 62.0 ± 9.2 | 62.0 ± 9.0 | 0.822 |
Height (cm) | 161.2 ± 9.6 | 163.1 ± 7.3 | 0.286 |
Diabetes mellitus | 3 | 20 | 0.788 |
Hypertension | 7 | 46 | 0.674 |
ASA (I/II/III/IV) | 14/6/3/1 | 52/75/10/0 | 0.634 |
Anesthesia time (minutes) | 77.1 ± 38.2 | 54.1 ± 19.7 | 0.000* |
Hospital stay (days) | 9.1 ± 5.8 | 7.4 ± 4.6 | 0.110 |
Pathology (I/II) | 14/10 | 56/81 | 0.106 |
Smoking history (pack year) | 13.1 ± 17.7 | 18.4 ± 23.0 | 0.113 |
BCG treatment patients | 22 | 114 | 0.375 |
Values are mean ± standard deviation or numbers. No significant differences were detected, except in age and anesthesia time. *P < 0.05. ASA American Society of Anesthesiologists. BCG Bacillus Calmette-Guerin